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Background
Using immunosuppressive drugs in younger children
increases the risk of severe infections not seen in adult
patients, as immunity towards several viruses is lacking.
Aim
T oi n c r e a s et h ea w a r e n e s so ft h er i s ko fs e v e r ei n f e c -
tions in patients without immunity towards several
viruses.
Methods
In a seven-year-old boy treatment with methotrexate
and infliximab for bilateral panuveitis complicated by
glaucoma and cataract was initiated. During treatment
the uveitis went into remission and oral treatment with
prednisolone could be stopped. The intraocular pressure
dropped and surgical intervention for glaucoma was
cancelled. The child underwent screening for tuberculo-
sis before treatment was started. Also, as the child had
not received any vaccinations in his entire life, vaccina-
tion against measles, rubella and mumps (part of the
normal Danish vaccination strategy of children) was per-
formed before treatment.
After four months of treatment the boy showed signs
of chickenpox and was admitted to hospital due to viral
pneumonia. The immunosuppressive drugs were with-
drawn and antiviral treatment initiated immediately in
high doses. He developed progressively respiratory insuf-
ficiency and required mechanical ventilation and as the
condition worsened Extracorporeal Membrane Oxygena-
tion (ECMO). He finally died from increased intracranial
pressure due to encephalitis.
Conclusion
Before initiating treatment with immunosuppressive
drugs it is of severe importance to evaluate the immu-
nity of the patient towards viruses able of causing severe
infection. Vaccination prior to treatment must be
considered.
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